LC determination of oxcarbazepine and its active metabolite in human serum

H Levert1, P Odou, H Robert

  • 1EPSM Lille-métropole Hospital, 109 rue du Général Leclerc, Lille, Armentières, France.

Insights

A new HPLC method accurately measures oxcarbazepine and other antiepileptic drugs in plasma. This validated assay is crucial for managing refractory epilepsy patients on multiple medications.

Area of Science:

  • Pharmacology
  • Analytical Chemistry
  • Clinical Pharmacy

Background:

  • Refractory epilepsy affects 25% of patients, necessitating novel antiepileptic drugs (AEDs).
  • Oxcarbazepine, a carbamazepine analog, is a newer AED with potential pharmacokinetic interactions.
  • Accurate drug monitoring is essential for optimizing treatment and managing polypharmacy in epilepsy.

Purpose of the Study:

  • To develop and validate a high-performance liquid chromatography (HPLC) method for simultaneous quantification of key antiepileptic drugs.
  • To establish a reliable analytical tool for therapeutic drug monitoring of oxcarbazepine and related compounds.

Main Methods:

  • Plasma samples were treated with acetonitrile for protein precipitation.
  • Analysis was performed using a C18 reversed-phase column with UV detection at 240 nm.
  • Method validation followed European technical commission recommendations, assessing selectivity, linearity, quantification limits, and recovery.

Main Results:

  • The HPLC method demonstrated good selectivity for oxcarbazepine, 10-hydroxycarbamazepine, epoxycarbamazepine, carbamazepine, phenobarbital, and phenytoin.
  • Linearity was achieved across the entire concentration range for all compounds.
  • Quantification limits ranged from 0.58 to 3.5 µg/mL, with absolute recoveries between 84.76% and 105.15%.

Conclusions:

  • The validated HPLC method provides accurate and reliable simultaneous measurement of essential antiepileptic drugs.
  • This assay is suitable for therapeutic drug monitoring in epilepsy patients, particularly those on oxcarbazepine and potentially interacting comedications.
  • The method supports clinical management by enabling precise quantification of AED levels in complex treatment regimens.

Related Concept Videos

Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...